1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Nonsteriodal Anti-inflammatory Drugs
        1.2.3 Disease Modifying Antirheumatic Drugs
        1.2.4 Biologics
    1.3 Market by Application
        1.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Psoriatic Arthritis (PsA) Treatment Market Perspective (2017-2028)
    2.2 Psoriatic Arthritis (PsA) Treatment Growth Trends by Region
        2.2.1 Psoriatic Arthritis (PsA) Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Psoriatic Arthritis (PsA) Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Psoriatic Arthritis (PsA) Treatment Market Dynamics
        2.3.1 Psoriatic Arthritis (PsA) Treatment Industry Trends
        2.3.2 Psoriatic Arthritis (PsA) Treatment Market Drivers
        2.3.3 Psoriatic Arthritis (PsA) Treatment Market Challenges
        2.3.4 Psoriatic Arthritis (PsA) Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue
        3.1.1 Global Top Psoriatic Arthritis (PsA) Treatment Players by Revenue (2017-2022)
        3.1.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Psoriatic Arthritis (PsA) Treatment Revenue
    3.4 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio
        3.4.1 Global Psoriatic Arthritis (PsA) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis (PsA) Treatment Revenue in 2021
    3.5 Psoriatic Arthritis (PsA) Treatment Key Players Head office and Area Served
    3.6 Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
    3.7 Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Type
    4.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2023-2028)
5 Psoriatic Arthritis (PsA) Treatment Breakdown Data by Application
    5.1 Global Psoriatic Arthritis (PsA) Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Psoriatic Arthritis (PsA) Treatment Market Size (2017-2028)
    6.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type
        6.2.1 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022)
        6.2.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2028)
        6.2.3 North America Psoriatic Arthritis (PsA) Treatment Market Share by Type (2017-2028)
    6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application
        6.3.1 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022)
        6.3.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2028)
        6.3.3 North America Psoriatic Arthritis (PsA) Treatment Market Share by Application (2017-2028)
    6.4 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country
        6.4.1 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022)
        6.4.2 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size (2017-2028)
    7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type
        7.2.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Psoriatic Arthritis (PsA) Treatment Market Share by Type (2017-2028)
    7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application
        7.3.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Psoriatic Arthritis (PsA) Treatment Market Share by Application (2017-2028)
    7.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country
        7.4.1 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type
        8.2.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application
        8.3.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region
        8.4.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size (2017-2028)
    9.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type
        9.2.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Type (2017-2028)
    9.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application
        9.3.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Psoriatic Arthritis (PsA) Treatment Market Share by Application (2017-2028)
    9.4 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country
        9.4.1 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type
        10.2.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application
        10.3.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country
        10.4.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Introduction
        11.1.4 Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Details
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Introduction
        11.2.4 Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Developments
    11.3 AbbVie
        11.3.1 AbbVie Company Details
        11.3.2 AbbVie Business Overview
        11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Introduction
        11.3.4 AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.3.5 AbbVie Recent Developments
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Introduction
        11.4.4 Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.4.5 Novartis Recent Developments
    11.5 UCB
        11.5.1 UCB Company Details
        11.5.2 UCB Business Overview
        11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Introduction
        11.5.4 UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.5.5 UCB Recent Developments
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Introduction
        11.6.4 Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.6.5 Roche Recent Developments
    11.7 Bristol-Myers Squibb
        11.7.1 Bristol-Myers Squibb Company Details
        11.7.2 Bristol-Myers Squibb Business Overview
        11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Introduction
        11.7.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.7.5 Bristol-Myers Squibb Recent Developments
    11.8 Eli Lilly
        11.8.1 Eli Lilly Company Details
        11.8.2 Eli Lilly Business Overview
        11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Introduction
        11.8.4 Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.8.5 Eli Lilly Recent Developments
    11.9 Amgen
        11.9.1 Amgen Company Details
        11.9.2 Amgen Business Overview
        11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Introduction
        11.9.4 Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.9.5 Amgen Recent Developments
    11.10 AstraZeneca
        11.10.1 AstraZeneca Company Details
        11.10.2 AstraZeneca Business Overview
        11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Introduction
        11.10.4 AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.10.5 AstraZeneca Recent Developments
    11.11 Celgene
        11.11.1 Celgene Company Details
        11.11.2 Celgene Business Overview
        11.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Introduction
        11.11.4 Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
        11.11.5 Celgene Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Nonsteriodal Anti-inflammatory Drugs
    Table 3. Key Players of Disease Modifying Antirheumatic Drugs
    Table 4. Key Players of Biologics
    Table 5. Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Psoriatic Arthritis (PsA) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region (2017-2022)
    Table 9. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region (2023-2028)
    Table 11. Psoriatic Arthritis (PsA) Treatment Market Trends
    Table 12. Psoriatic Arthritis (PsA) Treatment Market Drivers
    Table 13. Psoriatic Arthritis (PsA) Treatment Market Challenges
    Table 14. Psoriatic Arthritis (PsA) Treatment Market Restraints
    Table 15. Global Psoriatic Arthritis (PsA) Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Players (2017-2022)
    Table 17. Global Top Psoriatic Arthritis (PsA) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2021)
    Table 18. Ranking of Global Top Psoriatic Arthritis (PsA) Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Psoriatic Arthritis (PsA) Treatment Product Solution and Service
    Table 22. Date of Enter into Psoriatic Arthritis (PsA) Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Application (2017-2022)
    Table 30. Global Psoriatic Arthritis (PsA) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Application (2023-2028)
    Table 32. North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Pfizer Company Details
    Table 63. Pfizer Business Overview
    Table 64. Pfizer Psoriatic Arthritis (PsA) Treatment Product
    Table 65. Pfizer Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 66. Pfizer Recent Developments
    Table 67. Johnson & Johnson Company Details
    Table 68. Johnson & Johnson Business Overview
    Table 69. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product
    Table 70. Johnson & Johnson Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 71. Johnson & Johnson Recent Developments
    Table 72. AbbVie Company Details
    Table 73. AbbVie Business Overview
    Table 74. AbbVie Psoriatic Arthritis (PsA) Treatment Product
    Table 75. AbbVie Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 76. AbbVie Recent Developments
    Table 77. Novartis Company Details
    Table 78. Novartis Business Overview
    Table 79. Novartis Psoriatic Arthritis (PsA) Treatment Product
    Table 80. Novartis Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 81. Novartis Recent Developments
    Table 82. UCB Company Details
    Table 83. UCB Business Overview
    Table 84. UCB Psoriatic Arthritis (PsA) Treatment Product
    Table 85. UCB Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 86. UCB Recent Developments
    Table 87. Roche Company Details
    Table 88. Roche Business Overview
    Table 89. Roche Psoriatic Arthritis (PsA) Treatment Product
    Table 90. Roche Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 91. Roche Recent Developments
    Table 92. Bristol-Myers Squibb Company Details
    Table 93. Bristol-Myers Squibb Business Overview
    Table 94. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product
    Table 95. Bristol-Myers Squibb Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 96. Bristol-Myers Squibb Recent Developments
    Table 97. Eli Lilly Company Details
    Table 98. Eli Lilly Business Overview
    Table 99. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product
    Table 100. Eli Lilly Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 101. Eli Lilly Recent Developments
    Table 102. Amgen Company Details
    Table 103. Amgen Business Overview
    Table 104. Amgen Psoriatic Arthritis (PsA) Treatment Product
    Table 105. Amgen Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 106. Amgen Recent Developments
    Table 107. AstraZeneca Company Details
    Table 108. AstraZeneca Business Overview
    Table 109. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product
    Table 110. AstraZeneca Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 111. AstraZeneca Recent Developments
    Table 112. Celgene Company Details
    Table 113. Celgene Business Overview
    Table 114. Celgene Psoriatic Arthritis (PsA) Treatment Product
    Table 115. Celgene Revenue in Psoriatic Arthritis (PsA) Treatment Business (2017-2022) & (US$ Million)
    Table 116. Celgene Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Psoriatic Arthritis (PsA) Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Nonsteriodal Anti-inflammatory Drugs Features
    Figure 3. Disease Modifying Antirheumatic Drugs Features
    Figure 4. Biologics Features
    Figure 5. Global Psoriatic Arthritis (PsA) Treatment Market Share by Application: 2021 VS 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Psoriatic Arthritis (PsA) Treatment Report Years Considered
    Figure 10. Global Psoriatic Arthritis (PsA) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Psoriatic Arthritis (PsA) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Psoriatic Arthritis (PsA) Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Psoriatic Arthritis (PsA) Treatment Market Share by Players in 2021
    Figure 14. Global Top Psoriatic Arthritis (PsA) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis (PsA) Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Psoriatic Arthritis (PsA) Treatment Revenue in 2021
    Figure 16. North America Psoriatic Arthritis (PsA) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2017-2028)
    Figure 18. North America Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2017-2028)
    Figure 19. North America Psoriatic Arthritis (PsA) Treatment Market Size Share by Country (2017-2028)
    Figure 20. United States Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Psoriatic Arthritis (PsA) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Psoriatic Arthritis (PsA) Treatment Market Size Share by Country (2017-2028)
    Figure 26. Germany Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Psoriatic Arthritis (PsA) Treatment Market Size Share by Region (2017-2028)
    Figure 36. China Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Psoriatic Arthritis (PsA) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Psoriatic Arthritis (PsA) Treatment Market Size Share by Country (2017-2028)
    Figure 46. Mexico Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size Share by Country (2017-2028)
    Figure 52. Turkey Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Psoriatic Arthritis (PsA) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Pfizer Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 56. Johnson & Johnson Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 57. AbbVie Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 58. Novartis Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 59. UCB Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 60. Roche Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 62. Eli Lilly Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 63. Amgen Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 64. AstraZeneca Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 65. Celgene Revenue Growth Rate in Psoriatic Arthritis (PsA) Treatment Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed